|
Market Cap (17-May) $7,515,405 (818th) |
Close (30-Jun) $0.004 |
Volume (30-Jun) 780,000 |
Shortsold (11-Feb) 8,518 (0.01%) (552nd) |
|
52w High $0.60 |
52w Low $0.095 |
P/E - |
EPS -0.11 |
IVX released this announcement to the ASX on 28 October 2021, 9:43. The announcement is marked as price sensitive, and is 10 page(s) in length and 672.06kb in size.
You can view all announcements from IVX and see how they appear on a price chart on the announcements page.
At the date of this announcement, IVX was 0.045% short sold according to ASIC data. It was ranked the 508th most shorted stock on the ASX. It remains ranked 552nd as of the latest reported data (11 February 2025).
| Other Recent Announcements from IVX | |
|---|---|
| Notification regarding unquoted securities - IVX | 11 May 2023, 8:38 |
| Change of Director's Interest Notice- Robert Merriel | 2 May 2023, 16:45 |
| Section 708A Cleansing Statement | 2 May 2023, 16:42 |
| Complete Regression of TNBC Tumours and Protective Immunity | 28 October 2021, 9:43 |
| Activities Report and Appendix 4C | 21 October 2021, 14:53 |
| Grant of ASX Waiver | 8 October 2021, 9:24 |
| Notice of Annual General Meeting/Proxy Form | 8 October 2021, 8:56 |
You must be logged in to post a reply.
Invion 